Primary Immunodeficiency Diseases Market : Trends, Opportunities and Forecasts upto 2023
The report analyzed the PIDD market from four prominent segments: by Disease, by Test, by Treatment and by Geography. In terms of market by disease the overall market is segmented into three broad categories: Antibody Deficiency, Cellular Immunodeficiency and Innate Immune Disorder. The antibody deficiency market is further analyzed and estimated for Agammaglobulinaemia, Common Variable Immune Deficiency, Selective IgA Deficiency, IgG Subclass Deficiency and Others. Whereas, cellular immunodeficiency market is sub-segmented into Ataxia Telangiectasia, Hyper IgM Syndromes, Wiskott-Aldrich Syndrome, DiGeorge Syndrome and Others. The innate immune disorder market include Complement Deficiencies, Hyper IgE Syndrome and Others. Moreover this report also studies the global market by test for diagnosis which encompasses blood test and prenatal testing. The global PIDD market by treatment include both qualitative and quantitative analysis for immunoglobulin replacement therapy, antibiotics therapy, stem cell and gene therapy and others.
Browse full report on Primary Immunodeficiency Diseases Market -
Geographically the market is divided into four major regions: North America, Europe, Asia Pacific and Rest of the World. The North America market incorporates The United States and Canada. The Europe region is accessed for Germany, United Kingdom and Rest of Europe. The Asia Pacific (APAC) market is sub-segmented into India, China and Rest of APAC. Rest of the World (RoW) include Latin America, Middle East and North Africa and Rest of RoW
Each of the aforementioned segments has been analyzed in detail for market trends, recent developments, outlook, and opportunities. The market overview section of the report explores market dynamics such as drivers, restraints, and opportunities that currently have strong impact on the global PIDD market which could influence the market in the future as well. Market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition between leading market players in the U.S. market. Porter’s five forces analysis is also explained in this section to understand the market in U.S. considering different parameters that have an impact on the sustainability of the companies operating in the market.
The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their respective market shares across the globe. The recommendations section included in the report would assist existing market players in targeting the end users and stakeholders of PIDD and also to those aiming to seek an entry. The report also profiles major players in the PIDD market based on various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Some of the leading companies operating in primary immunodeficiency diseases market across the globe. These encompasses Baxter International, Inc., Biotest AG, CSL Behring LLC, Bio Products Laboratory Ltd., Kedrion S.p.A., LFB S.A., Octapharma AG and Grifols S.A.
The global primary immunodeficiency diseases market is segmented into the following categories:
Global Primary Immunodeficiency Diseases Market, by Disease
Agammaglobulinaemia ((X-Linked and Autosomal Recessive)
Common Variable Immune Deficiency
Selective IgA Deficiency
IgG Subclass Deficiency
Hyper IgM Syndromes
Innate Immune Disorders
Hyper IgE Syndrome
Global Primary Immunodeficiency Diseases Market, by Test
Global Primary Immunodeficiency Diseases Market, by Treatment
Immunoglobulin Replacement Therapy
Stem cell and Gene Therapy
Global Primary Immunodeficiency Diseases Market, by Geography
Rest of the World
Request for sample of this report -
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Primary Immunodeficiency Diseases Market : Trends, Opportunities and Forecasts upto 2023 here
News-ID: 480404 • Views: 274
More Releases from Transparency Market Research - Pharmaceutical
Radiofrequency Ablation Devices Market by Product, Geography and Forecast to 202 …
Transparency Market Research (TMR) has published a new report titled, 'Radiofrequency Ablation Devices for Pain Management Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2027'. According to the report, the global radiofrequency ablation devices for pain management market was valued at US$ 543.0 Mn in 2018 and is projected to expand at a CAGR of above 11.0% from 2019 to 2027. Overview Radiofrequency ablation is a minimally invasive surgical
Antithrombin Market Estimated to Flourish by 2025
As per estimates presented in a report by TMR, the demand global antithrombin market will rise at a CAGR of 5.2% for the forecast period of 2017 to 2025. The market for antithrombin is predicted to attract a revenue of US$704.5 mn by the end of 2025 from US$448.2 mn in 2016. The global Antithrombin market is consolidated in nature with a few small-scale vendors that operate in regional markets and
Cancer Vaccines Market - Industrial applications witness fastest growth up to 20 …
Vaccines are medicines that stimulate the immune system of the body to protect against foreign substances. The stimulated immune system destroys foreign bodies and remembers it. Vaccines work on this principle of memorizing foreign particle and prevent infection likely to be caused by this foreign particle when it invades again. Cancer vaccines are medicines categorized as biological response modifiers. These modifiers work by stimulating the immune system to fight against
Bipolar Disorder (BPD) Market - Global Industry Growth and Forecast 2017 - 2025
Bipolar disorder, commonly known as manic depression, is a type of mental illness which is characterized by mood swings. Mood episodes are of two types: manic and depressive episodes. The changes in the mental state bring out sudden high or low moods in a person. An individual suffering from bipolar disorder can be happy, joyful, and energized at a particular moment and can also be sad, hopeless, and sluggish at
More Releases for Disease
Infectious Disease Diagnostic Market
Infectious disease diagnostics involves identifying the presence of foreign antigen/organism using diagnostic tools such as kits. Most of the standard diagnostic test kits currently available are for bacterial infections and sexually transmitted diseases. However, in future these diagnostic tests are expected to be replaced by molecular techniques. The global infectious disease diagnostic market is expected to witness significant growth during the forecast period due to increasing prevalence of infectious diseases, increased
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene
Gaucher Disease Treatment Market, by Disease Type, Therapy Type
Gaucher disease is an autosomal recessive inherited metabolism disorder where a type of fat (lipid) called glucocerebroside is unable to degrade. Body synthesis enzyme called glucocerebrosidase, which breakdowns and reprocesses glucocerebroside. Gaucher disease is caused by mutations of a single gene called GBA, which leads to very low levels of glucocerebrosidase enzyme leading to low degradation of glucocerebroside. There are three types of Gaucher disease namely: type 1, type 2,
Crohns Disease Treatment Market
Crohn’s disease is a chronic inflammatory bowel syndrome that causes inflammation in the gastrointestinal tract. Inflammation can take place anywhere between mouth to anus. It commonly affects end of small intestine (Ileum) and beginning of the colon. Common symptoms of Crohn’s disease from mild to severe intensity include abdominal pain, frequent diarrhea, reduced appetite, and fever. Sometimes rectal bleeding is also observed due to fissures from inflammation at anal canal.
Peyronie’s Disease Treatment Market
Peyronie's disease (PD) is condition wherein the penis is curved or bent due to development of plaque or a fibrous scar tissue inside the penis. This condition can cause painful erections and the penis gets bent while it is erected. The bent is towards the side where plaque is being formed i.e. either downwards or upwards. The condition is identified by a major bend or pain. In a few people
Cardiovascular Disease Prevention
Reduce Your Risk of Cardiovascular Disease… Useful information about how you can lower your blood pressure, lower cholesterol, and decrease your risk of heart disease. One person dies every 30 seconds from heart disease. That's over 2,600 people every single day!! Cardiovascular disease refers to any disorder in any of the various parts of your cardiovascular system, which includes your heart and blood vessels. The heart is the